Prescriber confusion stymies tamoxifen uptake

Australian clinicians are confused as to who should take responsibility for prescribing risk-reducing medications such as tamoxifen to prevent breast cancer in women, according to a survey of cancer specialists.

And despite potential huge demand by women following the PBS listing of tamoxifen, many specialists are reluctant to take on more patients.

The survey asked 100 genetic health professionals, medical oncologists and